TWIST1 and glioblastoma: In order to investigate how MN-anti-miR10b affects EMT status of GBM cells, we analyzed the expression of two current common markers of EMT, Twist1 and Fibronectin [both upregulated in EMT (Kubelt et al., 2015)] subjected to treatments with MN-anti-miR10b, MN-scr-miR and PBS as control.